Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct

Virology Journal

Volumn 9, Issue , 2012, Pages

  Zhang, Tao ^a   Cheng, Tong ^a   Wei, Lihua ^a   Cai, Yijun ^a   Yeo, Anthony Et ^a   Han, Jiahuai ^a   Yuan, Y Adam ^a,b   Zhang, Jun ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Artificial polycistronic transcript; HIV replication inhibition; RNA interference; siRNA; Viral escape

Indexed keywords

MICRORNA; SHORT HAIRPIN RNA; STAT1 PROTEIN; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT;

3' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENVELOPE GENE; GENE CONSTRUCT; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REPORTER GENE; RNA INTERFERENCE; RNA SEQUENCE; VIRUS GENE; VIRUS REPLICATION; CELL LINE; CONFORMATION; DRUG EFFECT; GENETIC RECOMBINATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL AGENTS; BASE SEQUENCE; BIOLOGICAL AGENTS; CELL LINE; HIV-1; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RECOMBINATION, GENETIC; VIRUS REPLICATION;

EID: 84862251469     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-118     Document Type: Article

References (41)

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC, Nature 1998 391 806 811 10.1038/35888 9486653
2. Biochemical mechanisms of the RNA-induced silencing complex. Paroo Z, Liu Q, Wang X, Cell Res 2007 17 187 194 17310219
3. Mechanisms of gene silencing by double-stranded RNA. Meister G, Tuschl T, Nature 2004 431 343 349 10.1038/nature02873 15372041
4. MicroRNA genes are transcribed by RNA polymerase II. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN, Embo J 2004 23 4051 4060 10.1038/sj.emboj. 7600385 15372072
5. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Cai X, Hagedorn CH, Cullen BR, Rna 2004 10 1957 1966 10.1261/rna.7135204 15525708
6. The nuclear RNase III Drosha initiates microRNA processing. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN, Nature 2003 425 415 419 10.1038/nature01957 14508493
7. The Drosha-DGCR8 complex in primary microRNA processing. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN, Genes Dev 2004 18 3016 3027 10.1101/gad.1262504 15574589
8. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Yi R, Qin Y, Macara IG, Cullen BR, Genes Dev 2003 17 3011 3016 10.1101/gad.1158803 14681208
9. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R, Nature 2005 436 740 744 10.1038/nature03868 15973356
10. MicroRNA biogenesis: coordinated cropping and dicing. Kim VN, Nat Rev Mol Cell Biol 2005 6 376 385 15852042
11. Transcription and processing of human microRNA precursors. Cullen BR, Mol Cell 2004 16 861 865 10.1016/j.molcel.2004.12.002 15610730
12. Clustering and conservation patterns of human microRNAs. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H, Nucleic Acids Res 2005 33 2697 2706 10.1093/nar/gki567 15891114
13. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K, Blood 2009 113 396 402 18941111
14. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Petrocca F, Vecchione A, Croce CM, Cancer Res 2008 68 8191 8194 10.1158/0008-5472.CAN-08-1768 18922889
15. Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery. Jia F, Zhang YZ, Liu CM, J Biotechnol 2007 128 32 40 10.1016/j.jbiotec.2006.09.007 17049658
16. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)(c)(-/-)) mouse model. Ter Brake O, Legrand N, von Eije KJ, Centlivre M, Spits H, Weijer K, Blom B, Berkhout B, Gene Ther 2009 16 148 153 10.1038/gt.2008.124 18668146
17. Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Chevalier C, Saulnier A, Benureau Y, Flechet D, Delgrange D, Colbere-Garapin F, Wychowski C, Martin A, Mol Ther 2007 15 1452 1462 10.1038/sj.mt.6300186 17505476
18. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, Hellermann G, Behera S, Singam R, Lockey RF, Mohapatra SS, Nat Med 2005 11 56 62 10.1038/nm1174 15619625
19. Protection against lethal influenza virus challenge by RNA interference in vivo. Tompkins SM, Lo CY, Tumpey TM, Epstein SL, Proc Natl Acad Sci U S A 2004 101 8682 8686 10.1073/pnas.0402630101 15173583
20. Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA. Ansar M, Ashfaq UA, Shahid I, Sarwar MT, Javed T, Rehman S, Hassan S, Riazuddin S, Virol J 2011 8 203 10.1186/1743-422X-8-203 21535893
21. Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D gene. Du J, Gao S, Luo J, Zhang G, Cong G, Shao J, Lin T, Cai X, Chang H, Virol J 2011 8 292 10.1186/1743-422X-8-292 21663611
22. Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV. Jahan S, Khaliq S, Samreen B, Ijaz B, Khan M, Ahmad W, Ashfaq UA, Hassan S, Virol J 2011 8 295 10.1186/1743-422X-8-295 21663667
23. Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing. Son J, Uchil PD, Kim YB, Shankar P, Kumar P, Lee SK, Biochem Biophys Res Commun 2008 374 214 218 10.1016/j.bbrc.2008.06.125 18619945
24. Genetic therapies against HIV. Rossi JJ, June CH, Kohn DB, Nat Biotechnol 2007 25 1444 1454 10.1038/nbt1367 18066041
25. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5alpha protein, a CCR5 shRNA, and a TAR decoy. Anderson JS, Javien J, Nolta JA, Bauer G, Mol Ther 2009 17 2103 2114 10.1038/mt.2009.187 19690520
26. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B, Nucleic Acids Res 2005 33 796 804 10.1093/nar/gki220 15687388
27. Human immunodeficiency virus type 1 escapes from RNA interference- mediated inhibition. Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B, J Virol 2004 78 2601 2605 10.1128/JVI.78.5.2601-2605. 2004 14963165
28. Human immunodeficiency virus type 1 escape from RNA interference. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B, J Virol 2003 77 11531 11535 10.1128/JVI.77.21.11531-11535.2003 14557638
29. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Liu YP, Haasnoot J, ter Brake O, Berkhout B, Konstantinova P, Nucleic Acids Res 2008 36 2811 2824 10.1093/nar/gkn109 18346971
30. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Brake OT, Hooft K, Liu YP, Centlivre M, Jasmijn von Eije K, Berkhout B, Mol Ther 2008 16 557 564 10.1038/sj.mt.6300382 18180777
31. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Aagaard LA, Zhang J, von Eije KJ, Li H, Saetrom P, Amarzguioui M, Rossi JJ, Gene Ther 2008 15 1536 1549 10.1038/gt.2008.147 18800151
32. Inhibition of rabies virus replication by multiple artificial microRNAs. Israsena N, Supavonwong P, Ratanasetyuth N, Khawplod P, Hemachudha T, Antiviral Res 2009 84 76 83 10.1016/j.antiviral.2009.07.012 19646485
33. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA, Nature 2006 441 537 541 10.1038/nature04791 16724069
34. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Lo HL, Chang T, Yam P, Marcovecchio PM, Li S, Zaia JA, Yee JK, Gene Ther 2007 14 1503 1512 10.1038/sj.gt.3303011 17805304
35. Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response. Dang LT, Kondo H, Aoki T, Hirono I, Antiviral Res 2008 80 316 323 10.1016/j.antiviral.2008.07.005 18687362
36. Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes. Veres G, Escaich S, Baker J, Barske C, Kalfoglou C, Ilves H, Kaneshima H, Bohnlein E, J Virol 1996 70 8792 8800 8971008
37. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ, Proc Natl Acad Sci U S A 2005 102 13212 13217 10.1073/pnas.0506306102 16141338
38. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. Saayman S, Barichievy S, Capovilla A, Morris KV, Arbuthnot P, Weinberg MS, PLoS ONE 2008 3 2602 10.1371/journal.pone.0002602 18596982
39. Effective Pol III-expressed long hairpin RNAs targeted to multiple unique sites of HIV-1. Saayman SM, Arbuthnot P, Weinberg MS, Methods Mol Biol 2010 629 159 174 20387149
40. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. An DS, Qin FX, Auyeung VC, Mao SH, Kung SK, Baltimore D, Chen IS, Mol Ther 2006 14 494 504 10.1016/j.ymthe.2006.05.015 16844419
41. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. Kimpton J, Emerman M, J Virol 1992 66 2232 2239 1548759